Government ContextGovernment Context
ActivityRulesGrantsPress releasesHearingsBills
ViewsAgenciesTopicsOrganizationsCommitteesLegislators
PricingLog inCreate account

Table of contents

DetailsOverviewExplorerRelated

Cancer Clinical Trial Eligibility Criteria: Performance Status; Guidance for Industry, IRBs, and Clinical Investigators - Draft Guidance

FDA-2024-D-1377-0002Other
Comments
0
Awaiting comments
Deadline
Closed on Jun 26, 2024
Closed Jun 26, 2024
Net supportiSupport minus oppose · campaigns included
—
Document

Details

The document's own metadata, straight from the source system.

Title
Cancer Clinical Trial Eligibility Criteria: Performance Status; Guidance for Industry, IRBs, and Clinical Investigators - Draft Guidance
Posted
Apr 26, 2024
Comment period
Apr 26, 2024 – Jun 26, 2024
Agency
Food and Drug Administration (FDA)
Topics
View on regulations.gov ↗
Analysis

Overview

No comments yet.

Comments

Explorer

Every mirrored comment — filter by stance, campaign, or issue.

Filter:

No comments match.